Before piling into Woodford Patient Capital Trust, read this

Does the current 30%+ discount to NAV make Woodford Patient Capital Trust plc (LON: WPCT) a buy?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Is the recent move down in the share price of Woodford Patient Capital Trust (LSE: WPCT) justified, or is it an over-reaction to trouble in the Woodford Equity Income fund? If the move is a knee-jerk reaction by the market, does the big discount to net asset value make the stock a bargain?

The shock news this month that Woodford Investment Management has suspended dealings in its Equity Income fund seems to have dragged everything Woodford-related lower, including shares in WPCT. But let’s remember the trend in the shares has been down for some time, and I think there are good reasons for that.

Probabilities playing out in the trust?

When the share price was around 75p in May 2018, I argued that the probabilities were playing out among the trust’s speculative investee companies. As long as the trust doesn’t invest in any more profitless, jam-tomorrow firms, maybe the potential Woodford believes is in the portfolio will go on to shine through. Meanwhile, the losers could already have declined sufficiently to become less of a problem.

On that basis, I was cautiously optimistic about the trust’s prospects. However, all that has changed. Woodford’s reputation as a stock-picker is being dragged down by recent events too. The reason Equity Income fund investors have been running for the hills and withdrawing their money is that one after another Woodford’s share picks have been plunging. What if the share picks in the Woodford Patient Capital Trust are no good either?

Meanwhile, at the recent share price close to 56p, WPCT trades on a more-than-30% discount to the company’s own estimate of underlying net asset value. However, Rupert Hargreaves recently pointed out that most of the portfolio is invested in private companies rather than stock-market-listed firms. Private enterprises are hard to value, even though the trust has undertaken a number of independent valuations.

What if assumptions prove to be incorrect?

What if the estimates prove to be plain wrong? On top of that, what if the upside potential Woodford thinks he’s seeing in the enterprises he’s picked doesn’t materialise? Based on recent stock-picking performance, there’s every reason to suspect that Woodford could be ‘wrong’ about the investments in WPCT.

As investors ourselves, it’s risky enough trying to pick our own speculative ‘investments’. Often, things don’t work out as we hope and we end up losing money as share prices crash for one reason or another. So why add another layer of human judgement (or potential mis-judgement) to the stock-picking process by buying shares in a trust packed full of someone else’s speculative stock picks?

Despite the lure of a fat discount, I reckon the safest way is for me to avoid the shares of Woodford Patient capital Trust. It’s also a good idea for me to avoid profitless, speculative shares altogether and to focus on companies that have already proved their ability to turn a profit and increase it each year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »